Ricky Y. K. Man
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ricky Y. K. Man has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Hwee Teoh
Division of Cardiac Surgery (C.J.D., A.Z.H., A.K., A.Q., H.T., S.V.), St. Michael’s Hospital of Unity Health Toronto, Toronto, Ontario, Canada
5 shared publications - Wendy Keung
Dr. Li Dak-Sum Centre, The University of Hong Kong - Karolinska Institutet Collaboration in Regenerative Medicine, Hong Kong, China
5 shared publications - Adrian Quan
Division of Cardiac Surgery (C.J.D., A.Z.H., A.K., A.Q., H.T., S.V.), St. Michael’s Hospital of Unity Health Toronto, Toronto, Ontario, Canada
2 shared publications Paul M Vanhoutte
Department of Pharmacology, Faculty of Medicine, The University of Hong Kong, Level 2, Laboratory Block, Faculty of Medicine Building, 21 Sassoon Road, Hong Kong SAR, People's Republic of China
2 shared publicationsPaul M. Vanhoutte
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR
2 shared publicationsSusan W. S. Leung
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR
2 shared publications
Latest Publications
- Open Access
- 30 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e63199
Differential Ligand Binding Affinities of Human Estrogen Receptor-α Isoforms
Rapid non-genomic effects of 17β-estradiol are elicited by the activation of different estrogen receptor-α isoforms. Presence of surface binding sites for estrogen have been identified in cells transfected with full-length estrogen receptor-α66 (ER66) and the truncated isoforms, estrogen receptor-α46 (ER46) and estrogen receptor-α36 (ER36). However, the binding affinities of the membrane estrogen receptors (mERs) remain unknown due to the difficulty of developing of stable mER-transfected cell lines with sufficient mER density, which has largely hampered biochemical binding studies. The present study utilized cell-free expression systems to determine the binding affinities of 17β-estradiol to mERs, and the relationship among palmitoylation, membrane insertion and binding affinities. Saturation binding assays of human mERs revealed that [ 3 H]-17β-estradiol bound ER66 and ER46 with K d values of 68.81 and 60.72 pM, respectively, whereas ER36 displayed no specific binding within the tested concentration range. Inhibition of palmitoylation or removal of the nanolipoprotein particles, used as membrane substitute, reduced the binding affinities of ER66 and ER46 to 17β-estradiol. Moreover, ER66 and ER46 bound differentially with some estrogen receptor agonists and antagonists, and phytoestrogens. In particular, the classical estrogen receptor antagonist, ICI 182,780, had a higher affinity for ER66 than ER46. In summary, the present study defines the binding affinities for human estrogen receptor-α isoforms, and demonstrates that ER66 and ER46 show characteristics of mERs. The present data also indicates that palmitoylation and membrane insertion of mERs are important for proper receptor conformation allowing 17β-estradiol binding. The differential binding of ER66 and ER46 with certain compounds substantiates the prospect of developing mER-selective drugs.
- 30 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e63199
Open AccessDifferential Ligand Binding Affinities of Human Estrogen Receptor-α Isoforms
Rapid non-genomic effects of 17β-estradiol are elicited by the activation of different estrogen receptor-α isoforms. Presence of surface binding sites for estrogen have been identified in cells transfected with full-length estrogen receptor-α66 (ER66) and the truncated isoforms, estrogen receptor-α46 (ER46) and estrogen receptor-α36 (ER36). However, the binding affinities of the membrane estrogen receptors (mERs) remain unknown due to the difficulty of developing of stable mER-transfected cell lines with sufficient mER density, which has largely hampered biochemical binding studies. The present study utilized cell-free expression systems to determine the binding affinities of 17β-estradiol to mERs, and the relationship among palmitoylation, membrane insertion and binding affinities. Saturation binding assays of human mERs revealed that [ 3 H]-17β-estradiol bound ER66 and ER46 with K d values of 68.81 and 60.72 pM, respectively, whereas ER36 displayed no specific binding within the tested concentration range. Inhibition of palmitoylation or removal of the nanolipoprotein particles, used as membrane substitute, reduced the binding affinities of ER66 and ER46 to 17β-estradiol. Moreover, ER66 and ER46 bound differentially with some estrogen receptor agonists and antagonists, and phytoestrogens. In particular, the classical estrogen receptor antagonist, ICI 182,780, had a higher affinity for ER66 than ER46. In summary, the present study defines the binding affinities for human estrogen receptor-α isoforms, and demonstrates that ER66 and ER46 show characteristics of mERs. The present data also indicates that palmitoylation and membrane insertion of mERs are important for proper receptor conformation allowing 17β-estradiol binding. The differential binding of ER66 and ER46 with certain compounds substantiates the prospect of developing mER-selective drugs.
- 1 April 2008
- Published by EDP Sciences in Wuhan University Journal of Natural Sciences
- Vol. 13 (2) , 239-246
Identification of mucilage cavity as a significant microscopic characteristic existing in phloem instead of pith of Radix et Rhizoma Rhei
The morphologic and microscopic features of Radix et Rhizoma Rhei were studied. The study verified that the mucilage cavities did exist in phloem of rhizomes and roots or abnormal vascular bundles. Also, they were in similar distribution in three species of Radix et Rhizoma Rhei. The diagnostic characteristic for microscopic identification was found to be the similar distribution of abnormal vascular bundles in pith of rhizomes in all three species. And the appearance of the crude drug varied more depending on the plants’ geographical origin and different preliminary treatment on the spot of collection than on the species differences. Our findings, having not been delineated clearly so far in the previous reports, are helpful for clarifying current descriptions in different literatures or standards and make a full understanding on microscopic and macroscopic identification of Radix et Rhizoma Rhei.
- 1 April 2008
- Published by EDP Sciences in Wuhan University Journal of Natural Sciences
- Vol. 13 (2) , 239-246
Identification of mucilage cavity as a significant microscopic characteristic existing in phloem instead of pith of Radix et Rhizoma Rhei
The morphologic and microscopic features of Radix et Rhizoma Rhei were studied. The study verified that the mucilage cavities did exist in phloem of rhizomes and roots or abnormal vascular bundles. Also, they were in similar distribution in three species of Radix et Rhizoma Rhei. The diagnostic characteristic for microscopic identification was found to be the similar distribution of abnormal vascular bundles in pith of rhizomes in all three species. And the appearance of the crude drug varied more depending on the plants’ geographical origin and different preliminary treatment on the spot of collection than on the species differences. Our findings, having not been delineated clearly so far in the previous reports, are helpful for clarifying current descriptions in different literatures or standards and make a full understanding on microscopic and macroscopic identification of Radix et Rhizoma Rhei.
- 30 December 2007
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 311 (1-2) , 37-44
Genistein potentiates protein kinase A activity in porcine coronary artery
Soy consumption is associated with a lower risk of atherosclerotic disease in the oriental population. Genistein is a soy isoflavone bearing estrogenic properties. Previous experiments in our laboratory demonstrated the potentiation of endothelium-independent relaxation of coronary artery by both estrogen and genistein. The potentiating effects of both estrogen and genistein were mediated through the cAMP-signaling pathway. We hypothesize that genistein could enhance protein kinase A (PKA) activity in porcine coronary artery smooth muscle, thereby offering a mechanism for the potentiation of vascular relaxation by genistein. In our study, a high concentration of genistein (10−4.5 M) significantly increased PKA activity in porcine coronary artery rings. While genistein at 10−5.5 M and forskolin at 10−7 M had no effect on PKA activity, the combination of the two compounds at the prescribed concentrations caused a significant increase in PKA activity. The increase in PKA activity by genistein was abolished by SQ 22536 (adenylate cyclase blocker), but not by NF 449 (Gs protein blocker) or ICI 182780 (estrogen receptor antagonist). Our results suggest that the action of genistein is mediated via adenylate cyclase, but does not appear to involve Gs protein or ICI 182780-sensitive estrogen receptor.
- 30 December 2007
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 311 (1-2) , 37-44
Genistein potentiates protein kinase A activity in porcine coronary artery
Soy consumption is associated with a lower risk of atherosclerotic disease in the oriental population. Genistein is a soy isoflavone bearing estrogenic properties. Previous experiments in our laboratory demonstrated the potentiation of endothelium-independent relaxation of coronary artery by both estrogen and genistein. The potentiating effects of both estrogen and genistein were mediated through the cAMP-signaling pathway. We hypothesize that genistein could enhance protein kinase A (PKA) activity in porcine coronary artery smooth muscle, thereby offering a mechanism for the potentiation of vascular relaxation by genistein. In our study, a high concentration of genistein (10−4.5 M) significantly increased PKA activity in porcine coronary artery rings. While genistein at 10−5.5 M and forskolin at 10−7 M had no effect on PKA activity, the combination of the two compounds at the prescribed concentrations caused a significant increase in PKA activity. The increase in PKA activity by genistein was abolished by SQ 22536 (adenylate cyclase blocker), but not by NF 449 (Gs protein blocker) or ICI 182780 (estrogen receptor antagonist). Our results suggest that the action of genistein is mediated via adenylate cyclase, but does not appear to involve Gs protein or ICI 182780-sensitive estrogen receptor.
- 26 June 2007
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 34 (8) , 822-826
NON‐GENOMIC VASCULAR ACTIONS OF FEMALE SEX HORMONES: PHYSIOLOGICAL IMPLICATIONS AND SIGNALLING PATHWAYS
SUMMARY: Epidemiological studies indicate a lower incidence of coronary heart disease in premenopausal women compared with age‐matched men and post‐menopausal women. Accumulating evidence suggests that this cardiovascular protection observed in premenopausal women is at least partially attributed to the direct action of oestrogens on the vascular system. Research focused on vascular actions of 17β‐oestradiol indicates that this female sex hormone favourably modulates vascular reactivity at physiological concentrations. The vascular actions of 17β‐oestradiol appear independent of its genomic actions. Both endothelium‐dependent and ‐independent signalling cascades have been implicated in the vascular effects of 17β‐oestradiol. However, clinical trials on hormone‐replacement therapy argue against a role of oestrogens in preventing the development of coronary heart disease. Supplementation with oestrogen is also complicated with the increased risk of breast and endometrial cancer. Hence, a better understanding of the vascular actions of 17β‐oestradiol will serve to enhance our understanding of its role in coronary heart disease.
- 26 June 2007
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 34 (8) , 822-826
NON‐GENOMIC VASCULAR ACTIONS OF FEMALE SEX HORMONES: PHYSIOLOGICAL IMPLICATIONS AND SIGNALLING PATHWAYS
SUMMARY: Epidemiological studies indicate a lower incidence of coronary heart disease in premenopausal women compared with age‐matched men and post‐menopausal women. Accumulating evidence suggests that this cardiovascular protection observed in premenopausal women is at least partially attributed to the direct action of oestrogens on the vascular system. Research focused on vascular actions of 17β‐oestradiol indicates that this female sex hormone favourably modulates vascular reactivity at physiological concentrations. The vascular actions of 17β‐oestradiol appear independent of its genomic actions. Both endothelium‐dependent and ‐independent signalling cascades have been implicated in the vascular effects of 17β‐oestradiol. However, clinical trials on hormone‐replacement therapy argue against a role of oestrogens in preventing the development of coronary heart disease. Supplementation with oestrogen is also complicated with the increased risk of breast and endometrial cancer. Hence, a better understanding of the vascular actions of 17β‐oestradiol will serve to enhance our understanding of its role in coronary heart disease.
- 26 June 2007
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 34 (8) , 799-800
INTRODUCTION
- 26 June 2007
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 34 (8) , 799-800
INTRODUCTION
- 1 December 2005
- Published by Wiley in British Journal of Pharmacology
- Vol. 146 (8) , 1148-1155
Nongenomic responses to 17β‐estradiol in male rat mesenteric arteries abolish intrinsic gender differences in vascular responses
The aim of the present study was to investigate the gender differences in the acute effects of 17β‐estradiol on the rat superior mesenteric artery. Isometric tension was measured in rings of mesenteric arteries from both male and female Sprague–Dawley rats. Relaxation to acetylcholine was not significantly different between arteries (with endothelium) from male and female rats in the absence or presence of 17β‐estradiol. After blockade of endothelium‐dependent hyperpolarizations with apamin (0.3 μM) plus charybdotoxin (0.1 μM), acute exposure to 17β‐estradiol (1 nM) for 30 min resulted in enhancement of relaxation to acetylcholine in arteries from male but not female rats. After acute exposure to 17β‐estradiol, mesenteric arteries from male rats were more sensitive to sodium nitroprusside than arteries from female rats. Contractions of mesenteric arteries to phenylephrine and 9,11‐dideoxy‐11α,9α‐epoxymethanoprostaglandin F2α (U46619) were greater in arteries from male rats than female rats. This difference was not detected after acute exposure to 17β‐estradiol. In preparations without endothelium, the enhancement of relaxation and reduction in contraction in arteries from male rats were preserved. These results suggest that there exists a gender difference in the response to the acute nongenomic modulatory effect of 17β‐estradiol in rat mesenteric arteries. Arteries from male rats seem to be more sensitive to the modulatory effects of 17β‐estradiol than arteries from female rats. The effect appears to be mainly at the level of the vascular smooth muscles. British Journal of Pharmacology (2005) 146, 1148–1155. doi:10.1038/sj.bjp.0706422
- 1 December 2005
- Published by Wiley in British Journal of Pharmacology
- Vol. 146 (8) , 1148-1155
Nongenomic responses to 17β‐estradiol in male rat mesenteric arteries abolish intrinsic gender differences in vascular responses
The aim of the present study was to investigate the gender differences in the acute effects of 17β‐estradiol on the rat superior mesenteric artery. Isometric tension was measured in rings of mesenteric arteries from both male and female Sprague–Dawley rats. Relaxation to acetylcholine was not significantly different between arteries (with endothelium) from male and female rats in the absence or presence of 17β‐estradiol. After blockade of endothelium‐dependent hyperpolarizations with apamin (0.3 μM) plus charybdotoxin (0.1 μM), acute exposure to 17β‐estradiol (1 nM) for 30 min resulted in enhancement of relaxation to acetylcholine in arteries from male but not female rats. After acute exposure to 17β‐estradiol, mesenteric arteries from male rats were more sensitive to sodium nitroprusside than arteries from female rats. Contractions of mesenteric arteries to phenylephrine and 9,11‐dideoxy‐11α,9α‐epoxymethanoprostaglandin F2α (U46619) were greater in arteries from male rats than female rats. This difference was not detected after acute exposure to 17β‐estradiol. In preparations without endothelium, the enhancement of relaxation and reduction in contraction in arteries from male rats were preserved. These results suggest that there exists a gender difference in the response to the acute nongenomic modulatory effect of 17β‐estradiol in rat mesenteric arteries. Arteries from male rats seem to be more sensitive to the modulatory effects of 17β‐estradiol than arteries from female rats. The effect appears to be mainly at the level of the vascular smooth muscles. British Journal of Pharmacology (2005) 146, 1148–1155. doi:10.1038/sj.bjp.0706422
- 29 January 2005
- Published by Wiley in British Journal of Pharmacology
- Vol. 144 (1) , 71-79
Acute impairment of contractile responses by 17β-estradiol is cAMP and protein kinase G dependent in vascular smooth muscle cells of the porcine coronary arteries
The aim of the present study was to investigate the involvement of adenosine 3',5'-cyclic monophosphate (cAMP) cascade in the acute impairment of contraction by 17beta-estradiol in porcine coronary arteries, and to elucidate the signaling pathway leading to the activation of this cascade by the hormone. Isometric tension was recorded in isolated rings of porcine coronary arteries. The contraction to U46619 was reduced significantly following 30 min incubation with 1 nM 17beta-estradiol or 1 nM isoproterenol. There was no additive effect when 17beta-estradiol and isoproterenol were administered together. The effect of 17beta-estradiol was mimicked by both the cyclic AMP analogue 8-Br-cAMP and the guanosine 3',5'-cyclic monophosphate (cyclic GMP) analogue 8-Br-cGMP. In rings with and without endothelium, the modulatory effect of 17beta-estradiol was abolished by the adenylyl cyclase inhibitor, SQ 22536, but was unaffected by the guanylyl cyclase inhibitor, ODQ. Both the cAMP antagonist Rp-8-Br-cAMPS and the cGMP antagonist inhibitor Rp-8-Br-cGMPS inhibited the effect of 17beta-estradiol. The effect of 17beta-estradiol was unaffected by the protein kinase A inhibitor, KT5720, but was abolished by the protein kinase G (PKG) inhibitor, KT5823, which also abolished the effect of isoproterenol. These data support our earlier findings that 17beta-estradiol (1 nM) acutely impairs contractile responses of porcine coronary arteries in vitro. This acute effect of 17beta-estradiol involves cAMP in vascular smooth muscles and the activation of PKG.
- 29 January 2005
- Published by Wiley in British Journal of Pharmacology
- Vol. 144 (1) , 71-79
Acute impairment of contractile responses by 17β-estradiol is cAMP and protein kinase G dependent in vascular smooth muscle cells of the porcine coronary arteries
The aim of the present study was to investigate the involvement of adenosine 3',5'-cyclic monophosphate (cAMP) cascade in the acute impairment of contraction by 17beta-estradiol in porcine coronary arteries, and to elucidate the signaling pathway leading to the activation of this cascade by the hormone. Isometric tension was recorded in isolated rings of porcine coronary arteries. The contraction to U46619 was reduced significantly following 30 min incubation with 1 nM 17beta-estradiol or 1 nM isoproterenol. There was no additive effect when 17beta-estradiol and isoproterenol were administered together. The effect of 17beta-estradiol was mimicked by both the cyclic AMP analogue 8-Br-cAMP and the guanosine 3',5'-cyclic monophosphate (cyclic GMP) analogue 8-Br-cGMP. In rings with and without endothelium, the modulatory effect of 17beta-estradiol was abolished by the adenylyl cyclase inhibitor, SQ 22536, but was unaffected by the guanylyl cyclase inhibitor, ODQ. Both the cAMP antagonist Rp-8-Br-cAMPS and the cGMP antagonist inhibitor Rp-8-Br-cGMPS inhibited the effect of 17beta-estradiol. The effect of 17beta-estradiol was unaffected by the protein kinase A inhibitor, KT5720, but was abolished by the protein kinase G (PKG) inhibitor, KT5823, which also abolished the effect of isoproterenol. These data support our earlier findings that 17beta-estradiol (1 nM) acutely impairs contractile responses of porcine coronary arteries in vitro. This acute effect of 17beta-estradiol involves cAMP in vascular smooth muscles and the activation of PKG.
- 1 January 2004
- Published by Springer Nature
- p. 513-524
Phytoestrogens and Cardiovascular Disorders
- 1 April 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (8) , 1739-1747
Enhanced relaxation of porcine coronary arteries after acute exposure to a physiological level of 17β‐estradiol involves non‐genomic mechanisms and the cyclic AMP cascade
The present study extends our previous finding that the endothelium‐independent relaxation in porcine coronary artery rings is enhanced after short‐term (20 min) exposure to a physiological concentration (1 nM) of 17β‐estradiol and demonstrates that this effect may be attributable to activation of the cyclic AMP pathway. Isometric tension was recorded in isolated rings of porcine coronary arteries. Relaxation by levcromakalim and sodium nitroprusside, but not bradykinin and calcium ionophore A23187, were significantly potentiated following 20 min treatment with 1 nM 17β‐estradiol. This enhancing effect was insensitive to the transcriptional and translational inhibitors, actinomycin D and cycloheximide respectively and absent following repeated washing of the rings prior to construction of relaxation‐response curves. The potentiating actions of 1 nM 17β‐estradiol on endothelium‐independent relaxation were mimicked by the cyclic AMP analogue 8‐Bromo‐cyclic AMP and the protein kinase A activator Sp‐cyclic AMPS but not by the cyclic GMP analogue 8‐Bromo‐cyclic GMP. The modulatory effect of 17β‐estradiol was increased in the presence of the phosphodiesterase inhibitor 3‐isobutyl‐1‐methylxanthine. The cyclic AMP‐dependent protein kinase A inhibitor Rp‐cyclic AMPS, but not the cyclic GMP antagonist Rp‐8‐Bromo‐cyclic GMPS, effectively inhibited the enhancing effects 1 M 17β‐estradiol had on the relaxation responses of levcromakalim and sodium nitroprusside. These data support our earlier findings that physiologically relevant concentrations of 17β‐estradiol can acutely modify vasorelaxation in vitro. Furthermore, we report that this short‐term effect of 17β‐estradiol on vasorelaxation appears to be mediated via non‐genomic pathways and involves the cyclic AMP cascade. British Journal of Pharmacology (2000) 129, 1739–1747; doi:10.1038/sj.bjp.0703252
- 1 April 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (8) , 1739-1747
Enhanced relaxation of porcine coronary arteries after acute exposure to a physiological level of 17β‐estradiol involves non‐genomic mechanisms and the cyclic AMP cascade
The present study extends our previous finding that the endothelium‐independent relaxation in porcine coronary artery rings is enhanced after short‐term (20 min) exposure to a physiological concentration (1 nM) of 17β‐estradiol and demonstrates that this effect may be attributable to activation of the cyclic AMP pathway. Isometric tension was recorded in isolated rings of porcine coronary arteries. Relaxation by levcromakalim and sodium nitroprusside, but not bradykinin and calcium ionophore A23187, were significantly potentiated following 20 min treatment with 1 nM 17β‐estradiol. This enhancing effect was insensitive to the transcriptional and translational inhibitors, actinomycin D and cycloheximide respectively and absent following repeated washing of the rings prior to construction of relaxation‐response curves. The potentiating actions of 1 nM 17β‐estradiol on endothelium‐independent relaxation were mimicked by the cyclic AMP analogue 8‐Bromo‐cyclic AMP and the protein kinase A activator Sp‐cyclic AMPS but not by the cyclic GMP analogue 8‐Bromo‐cyclic GMP. The modulatory effect of 17β‐estradiol was increased in the presence of the phosphodiesterase inhibitor 3‐isobutyl‐1‐methylxanthine. The cyclic AMP‐dependent protein kinase A inhibitor Rp‐cyclic AMPS, but not the cyclic GMP antagonist Rp‐8‐Bromo‐cyclic GMPS, effectively inhibited the enhancing effects 1 M 17β‐estradiol had on the relaxation responses of levcromakalim and sodium nitroprusside. These data support our earlier findings that physiologically relevant concentrations of 17β‐estradiol can acutely modify vasorelaxation in vitro. Furthermore, we report that this short‐term effect of 17β‐estradiol on vasorelaxation appears to be mediated via non‐genomic pathways and involves the cyclic AMP cascade. British Journal of Pharmacology (2000) 129, 1739–1747; doi:10.1038/sj.bjp.0703252
- 1 April 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (7) , 1301-1308
Differential effects of 17β‐estradiol and testosterone on the contractile responses of porcine coronary arteries
We investigated the effects of short‐term exposure to physiological levels of 17β‐estradiol and testosterone on vasocontractile responses in porcine coronary artery rings. Concentration‐response curves to endothelin‐1, 5‐hydroxytryptamine, the thromboxane analogue U46619 and KCl were constructed in endothelium‐intact and endothelium‐disrupted artery rings. Thirty minutes exposure to 17β‐estradiol (1 and 30 nM) significantly attenuated vasoconstriction to endothelin‐1, 5‐hydroxytryptamine and U46619. Conversely, the same concentrations of testosterone significantly potentiated responses elicited by these contractile agents. These inhibitory effects of 17β‐estradiol and enhancing actions of testosterone on contractions were endothelium‐independent. KCl‐mediated contractions were unaffected by the presence of either sex hormones. The oestrogen receptor antagonists, tamoxifen (10 μM) and ICI 182,780 (10 μM), were unable to reverse the inhibitory influence 1 nM 17β‐estradiol had on the agonist‐mediated contractile responses. Similarly, the androgen receptor antagonists, flutamide (10 μM) and cyproterone acetate (10 μM), failed to affect the potentiating activities of 1 nM testosterone. The alteration in vasoconstrictive responses observed following acute exposure to either 1 nM 17β‐estradiol and 1 nM testosterone were apparent even in the presence of the protein synthesis inhibitor cycloheximide (10 μM) and the transcription inhibitor actinomycin D (10 μM). In conclusion, we report a unique type of sex hormone action on the coronary vasculature. These events occur at low nanomolar concentrations of 17β‐estradiol and testosterone, are insensitive to conventional sex hormone receptor antagonists, are not blocked by de novo protein synthesis inhibitors and have rapid time‐courses that are uncharacteristic of classical genomic activities. British Journal of Pharmacology (2000) 129, 1301–1308; doi:10.1038/sj.bjp.0703164
- 1 April 2000
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (7) , 1301-1308
Differential effects of 17β‐estradiol and testosterone on the contractile responses of porcine coronary arteries
We investigated the effects of short‐term exposure to physiological levels of 17β‐estradiol and testosterone on vasocontractile responses in porcine coronary artery rings. Concentration‐response curves to endothelin‐1, 5‐hydroxytryptamine, the thromboxane analogue U46619 and KCl were constructed in endothelium‐intact and endothelium‐disrupted artery rings. Thirty minutes exposure to 17β‐estradiol (1 and 30 nM) significantly attenuated vasoconstriction to endothelin‐1, 5‐hydroxytryptamine and U46619. Conversely, the same concentrations of testosterone significantly potentiated responses elicited by these contractile agents. These inhibitory effects of 17β‐estradiol and enhancing actions of testosterone on contractions were endothelium‐independent. KCl‐mediated contractions were unaffected by the presence of either sex hormones. The oestrogen receptor antagonists, tamoxifen (10 μM) and ICI 182,780 (10 μM), were unable to reverse the inhibitory influence 1 nM 17β‐estradiol had on the agonist‐mediated contractile responses. Similarly, the androgen receptor antagonists, flutamide (10 μM) and cyproterone acetate (10 μM), failed to affect the potentiating activities of 1 nM testosterone. The alteration in vasoconstrictive responses observed following acute exposure to either 1 nM 17β‐estradiol and 1 nM testosterone were apparent even in the presence of the protein synthesis inhibitor cycloheximide (10 μM) and the transcription inhibitor actinomycin D (10 μM). In conclusion, we report a unique type of sex hormone action on the coronary vasculature. These events occur at low nanomolar concentrations of 17β‐estradiol and testosterone, are insensitive to conventional sex hormone receptor antagonists, are not blocked by de novo protein synthesis inhibitors and have rapid time‐courses that are uncharacteristic of classical genomic activities. British Journal of Pharmacology (2000) 129, 1301–1308; doi:10.1038/sj.bjp.0703164